Published in Gastroenterology on December 01, 1992
Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc Natl Acad Sci U S A (2005) 1.87
Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest (1993) 1.55
Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse. Dig Dis Sci (2000) 1.55
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg (1999) 1.34
Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch (2003) 1.33
Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol (2002) 1.28
Keratinocyte growth factor induces pancreatic ductal epithelial proliferation. Am J Pathol (1994) 1.14
Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest (1999) 1.11
Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol (1994) 1.07
Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci (1998) 1.02
Regulation of Cellular Identity in Cancer. Dev Cell (2015) 0.96
Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol (1995) 0.95
alpha2-macroglobulin- and murinoglobulin-1- deficient mice. A mouse model for acute pancreatitis. Am J Pathol (1999) 0.90
A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene. Ann Surg (1994) 0.89
Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha. Gut (1999) 0.86
Protein kinase C iota regulates pancreatic acinar-to-ductal metaplasia. PLoS One (2012) 0.85
Transmembrane and soluble isoforms of heparin-binding epidermal growth factor-like growth factor regulate distinct processes in the pancreas. Gastroenterology (2009) 0.83
Effect of proton pump inhibitors on glycemic control in patients with diabetes. World J Diabetes (2015) 0.81
Islet growth factors: curing diabetes and preventing chronic pancreatitis? J Clin Invest (1993) 0.79
Histochemical analysis of hyperplastic stomach of TGF-alpha transgenic mice. Dig Dis Sci (1997) 0.79
Transition to pancreatic cancer in response to carcinogen. Langenbecks Arch Surg (2008) 0.78
Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes. Mcgill J Med (2009) 0.78
Function and regulation of gastrin in transgenic mice: a review. Yale J Biol Med (1994) 0.77
Aberrant acinar cell CA 19-9 expression and peri-insular acinar cell alterations in an adult human pancreas. Virchows Arch (2004) 0.75
Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev (1992) 2.59
Neonatal sunburn and melanoma in mice. Nature (2001) 2.25
Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci U S A (1994) 2.20
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res (1993) 2.09
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J (1998) 2.07
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90
Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J (1993) 1.86
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A (1996) 1.73
Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67
Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med (1994) 1.66
Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ (1995) 1.62
Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol (1995) 1.56
DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat Genet (1997) 1.55
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54
Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J (1992) 1.52
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene (2008) 1.48
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36
Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A (1996) 1.27
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest (1992) 1.20
Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development (1995) 1.14
Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. Oncogene (2010) 1.13
Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol (1994) 1.13
Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest (1999) 1.11
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Cancer Res (1994) 1.11
Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.10
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ (1995) 1.10
Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.05
Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology (1994) 1.04
Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res (2000) 0.99
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol (2000) 0.98
Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development. Pigment Cell Res (1999) 0.98
Regulation of terminal differentiation of zymogenic cells by transforming growth factor alpha in transgenic mice. Gastroenterology (1995) 0.97
Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett (2001) 0.96
Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol (1995) 0.95
Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens (1994) 0.95
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol (2001) 0.93
NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Mol Cell Biol (1998) 0.93
Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest (1997) 0.92
Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Cancer Res (1993) 0.91
Melanoma from bench to bedside: meeting report from the 6th international melanoma congress. Pigment Cell Melanoma Res (2009) 0.89
Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. Cancer Res (1997) 0.88
Changes in hemodynamics during isoflurane and propofol anesthesia: a comparison study. Neurol Res (2005) 0.88
Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord (1995) 0.87
Increased susceptibility to N-nitrosomethylurea gastric carcinogenesis in transforming growth factor alpha transgenic mice with gastric hyperplasia. Jpn J Cancer Res (1995) 0.86
Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation. Mol Carcinog (1997) 0.86
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens (1995) 0.85
Ulcerative proctitis, rectal prolapse, and intestinal pseudo-obstruction in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest (2001) 0.83
Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obes (1991) 0.83
The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase. Mol Cell Biol (2000) 0.83
Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell Growth Differ (1994) 0.82
Overexpression of a human transforming growth factor-alpha (TGF alpha) transgene reveals a dual antagonistic role of TGF alpha in female sexual development. Endocrinology (1994) 0.82
Transgenic mouse models of breast cancer. Breast Cancer Res Treat (1996) 0.82
Genetic dissection of melanoma pathways in the mouse. Semin Cancer Biol (2001) 0.82
[Sarcoidosis and clear cell carcinoma of the kidney: the sixth case?]. G Chir (2002) 0.81
Immunohistochemical detection of the c-met proto-oncogene product in the congenital melanocytic nevus of an infant with neurocutaneous melanosis. J Am Acad Dermatol (2001) 0.80
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease. Clin Pharmacol Ther (2007) 0.80
Heterotopic pregnancy following administration of human menopausal gonadotropin and following in vitro fertilization and embryo transfer: two case reports and review of the literature. Eur J Obstet Gynecol Reprod Biol (1995) 0.79
Histochemical analysis of hyperplastic stomach of TGF-alpha transgenic mice. Dig Dis Sci (1997) 0.79
Epidural anesthesia in an in vitro fertilization and embryo transfer program. J Assist Reprod Genet (1995) 0.78
Hepatocarcinogenesis in transgenic mice. Prog Clin Biol Res (1995) 0.78
Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. Int J Cardiol (1992) 0.78
Double-blind controlled study of rilmenidine versus hydrochlorothiazide in mild hypertension: clinical and renal haemodynamic evaluation. J Hum Hypertens (1993) 0.77
New options for aerodigestive tract replacement after extended pharyngolaryngectomy. Laryngoscope (2000) 0.77
Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo. Eur J Clin Pharmacol (1993) 0.77
Steroid hormone-dependent overexpression of cytochromes P450 2A in liver tumors of TGF alpha transgenic male mice. J Gastroenterol (1997) 0.76
General practitioners and mammographic screening uptake: influence of different modalities of general practitioner participation. Working Group. Tumori (2000) 0.76
[Gastric leiomyoma. Diagnostic and surgical problems]. G Chir (1999) 0.76
An epidermal growth factor receptor promoter construct selectively expresses in the thymus and spleen of transgenic mice. Cell Immunol (1993) 0.76
Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study. Cephalalgia (2007) 0.76
Mechanisms of DES carcinogenicity: effects of the TGF alpha transgene. Prog Clin Biol Res (1997) 0.76
Reconstruction of the pharynx and cervical esophagus using ileocolic free autograft. Am J Surg (1999) 0.75
[Non-parasitic splenic cysts]. G Chir (2001) 0.75
Histogenesis of anaplastic carcinomas of the thyroid, giant cell variety: immunocytochemical investigation. Appl Pathol (1985) 0.75
[Treatment with immunodepressors in cases of hemolytic diseases of the newborn caused by materno-fetal Rh isoimmunization]. Arch Ostet Ginecol (1982) 0.75
Reduction of EGF receptor synthesis by antisense RNA vectors. FEBS Lett (1986) 0.75
[Times of appearance of the arterial plethysmographic wave and the ultrasonogram in the study of arteriopathies]. Minerva Cardioangiol (1981) 0.75
[Diagnosis and therapy of female sterility secondary to cervical and endometrial inflammation]. Arch Ostet Ginecol (1981) 0.75
[Hereditary nonpolyposis colorectal cancer (Lynch syndrome): a review of the literature and case reports]. G Chir (2000) 0.75
[Etiopathogenetic and therapeutic problems of superficial thrombophlebitis during antiblastic therapy]. Ann Ital Chir (1981) 0.75
[Pentothal anesthesia and acid-base equilibrium in labor]. Arch Ostet Ginecol (1979) 0.75
[Ileocolic free autograft in advanced cervical oncology]. Acta Otorhinolaryngol Ital (1999) 0.75
[Functional exploration of fetal acid-base equilibrium in directed labor under propanidid anesthesia]. Arch Ostet Ginecol (1979) 0.75
[Doppler ultrasonography in phlebology]. Minerva Cardioangiol (1982) 0.75
Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation. Carcinogenesis (2001) 0.75
Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression. Mol Carcinog (1996) 0.75
[Current role of endoscopic ultrasonography in the treatment of colorectal neoplastic lesions]. G Chir (2002) 0.75
[Reconstructive strategies in head and neck cancer: case history review from 1992 to 1997 (154 cases)]. Acta Otorhinolaryngol Ital (1998) 0.75
[Treatment with immunodepressant drugs in neonatal hemolytic disease caused by Rh isoimmunization (preliminary note)]. Arch Ostet Ginecol (1982) 0.75
[Gamma-OH anesthesia and acid-base equilibrium in labor]. Arch Ostet Ginecol (1979) 0.75
[A method of localization of incompetant perforating veins by means of rheoscopy with ultrasonics]. Ann Ital Chir (1979) 0.75
[Current role of traditional endoscopy and prospects for virtual colonoscopy in the management of colorectal neoplastic lesions]. G Chir (2002) 0.75
Obesity, hypertension and atherosclerosis. Int Angiol (1993) 0.75
A 38 kg skin-reducing bilateral mastectomy: a unique case. J Plast Reconstr Aesthet Surg (2008) 0.75
Interactions of TCDD with signal transduction and neoplastic development in c-myc transgenic and TGF-alpha transgenic mice. Arch Toxicol Suppl (1997) 0.75
[Diagnostic problems and therapeutic prospects in hirsutism]. Arch Ostet Ginecol (1980) 0.75
[Mechanism of action of estradiol valerate. II. Changes in the genital tract of rats castrated and subjected to prolonged treatment]. Arch Ostet Ginecol (1978) 0.75